复星医药:公司董事会已分别审议通过A股回购方案及H股回购方案

互动易
26 Feb

有投资者向复星医药提问, 复星医药是怎么进行市值管理的?怎么长期低迷,在创新方面有进展吗?公司回答表示,投资者您好!公司始终将股东利益放在重要位置,高度重视市值管理工作。通过加强与投资者沟通交流,及时披露公司在业务进展、创新研发、业务合作等方面的信息,让市场充分了解公司价值。2025年1月22日,公司董事会已分别审议通过A股回购方案及H股回购方案,回购期间为自1月22日起6个月内,其中A股回购...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10